◆ 会议时间：2024年4月25日至27日
◆ 会议地点：韩国 首尔/Seoul

◆ 会议简介：

2024年第13届世界乳腺癌学术大会(GBCC2024)暨国际内镜和机器人乳腺外科研讨会(IERBS2024)将于2024年4月25日至27日在韩国首尔举行。

全球乳腺癌大会(GBCC)起始于2007年，是在韩国召开的亚洲最大最具影响力的乳腺癌会议之一，会议由韩国乳腺癌学会主办、韩国乳腺癌基金会支持，每年乳腺癌领域的众多专家学者聚集一堂，共同探讨有效诊断和治疗乳腺癌以及提高妇女健康的科学方法；GBCC原为每两年举办一次，自2016年开始，改为每年举办一次。GBCC汇聚了包括医学人士、科研人员、政策制定者、患者和监护人等来自社会各届宣的专业人士，共同探讨多种科学策略，有效地诊断和治疗乳腺癌，促进妇女健康。每届GBCC都有来自世界各地的一千三百余名专业人士与会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

世界乳腺癌学术大会
Global Breast Cancer Conference 2024 (GBCC 2024)
in conjunction with
International Endoscopic & Robotic Breast Surgery Symposium (IERBS 2024)

Date:
April 25 (Thu) – 27 (Sat), 2024

Venue:
Grand Walkerhill Seoul, Korea

Hosted by:
Korean Breast Cancer Society

摘要征文投稿：

• Registration and Abstract Submission Open： November 1 (Wed), 2023
• Abstract Submission Deadline: February 1st (Thu) 23:59 KST, 2024
• Notification of Acceptance: March, 2024

点此提交摘要>>>Submit Abstract>>>

Abstract Format

• Abstracts should be submitted online in English.
• The abstract structure should be as follows:
  - Abstract should be structured into the following headings: Background, Methods, Result, and Conclusion.
  - Abstract should not exceed 300 words. (Excluding Abstract Title and Spaces)
• The maximum number of authors is 30 per abstract.
• Figure, Table, Reference and Keyword are not allowed.
• If an author is affiliated with hospital as well as university, please enter the name of the hospital for which he/she works.

Conflicts of Interest

• The conflict of interest policy requirements applies to all abstract authors. Any potential conflict of interest must be indicated upon abstract submission. It is the responsibility of the Presenting Author to obtain disclosure information from all co-authors and to provide disclosure of all interests and relationships. This includes any financial or other relationships with commercial entities whose products or services are related to the subject matter in the manuscript, or sociopolitical issues that can cause conflict.

Encore Abstract Submission

• We are accepting Trial-in-Progress submissions and encore submissions.
• Encore submissions must:Have been presented solely in abstract form, including publication in conference proceedings. (Submissions which was already published in the full publication form in journals are NOT accepted.Include significant additional data from the previous presentation (as determined by the review committee).Include the abstract title, co-authors listed, the full abstract, and indicate if this is an encore presentation and, if so, where it was previously presented. This information should be presented both in abstract and in poster.
• It is the sole responsibility of the author to follow these rules.
• The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).
• Please note that encore abstracts can be disadvantaged in selecting awards and scholarships.

Dear Colleagues,

Welcome to the Global Breast Cancer Conference 2024 (GBCC 2024) in conjunction with International Endoscopic & Robotic Breast Surgery Symposium (IERBS 2024), which will be held from April 25 (Thu) to 27 (Sat), 2024 in Grand Walkerhill Seoul, Korea.

GBCC is one of the biggest breast cancer conferences in Asia and aims to lead Asia and move the world. GBCC takes place every year to gather people from all walks of life to come up with multi-scientific strategies to effectively diagnose and treat breast cancer and ultimately promote women's health.

GBCC 2023 was a 100% offline conference, held in-person after the COVID-19 pandemic. We are thrilled to announce that we received 2,516 breast cancer experts from 38 countries, setting a new record for attendance. We firmly believe that GBCC 2023 has opened an era that goes beyond the cure for breast cancer.

GBCC 2024 will be held in conjunction with International Endoscopic & Robotic Breast Surgery Symposium. We hope GBCC 2024 in conjunction with IERBS 2024 will be a valuable platform to shape a brighter future for breast cancer patients worldwide. Let us seize this opportunity to engage, network, and foster fruitful discussions that will drive us closer to our shared goal - a world without breast cancer.

We thank you for being part of this remarkable journey and for your keen interest in the upcoming GBCC, and we look forward to seeing you in April.

Thank you.

注册费：

Registration Fee

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。